Dr. Claudio Rigatto, MD
Claim this profileClinical Trials Claudio Rigatto, MD is currently running
More about Claudio Rigatto, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Claudio Rigatto, MD has experience with
- VIEWER Virtual Care Platform
Breakdown of trials Claudio Rigatto, MD has run
Chronic Kidney Disease
Chronic Renal Failure
Renal Disease
Kidney Failure
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Claudio Rigatto, MD specialize in?
Claudio Rigatto, MD focuses on Chronic Kidney Disease and Chronic Renal Failure. In particular, much of their work with Chronic Kidney Disease has involved treating patients, or patients who are undergoing treatment.
Is Claudio Rigatto, MD currently recruiting for clinical trials?
Yes, Claudio Rigatto, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Claudio Rigatto, MD has studied deeply?
Yes, Claudio Rigatto, MD has studied treatments such as VIEWER virtual care platform.
What is the best way to schedule an appointment with Claudio Rigatto, MD?
Apply for one of the trials that Claudio Rigatto, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.